PNC Financial Services Group Inc. Grows Position in Sotera Health (NASDAQ:SHC)

PNC Financial Services Group Inc. increased its position in Sotera Health (NASDAQ:SHC) by 39.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 9,302 shares of the company’s stock after purchasing an additional 2,627 shares during the period. PNC Financial Services Group Inc.’s holdings in Sotera Health were worth $127,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in SHC. Geode Capital Management LLC increased its stake in shares of Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after buying an additional 447,186 shares during the period. Maven Securities LTD purchased a new stake in Sotera Health during the 3rd quarter valued at about $1,670,000. Cerity Partners LLC bought a new stake in shares of Sotera Health during the third quarter valued at approximately $1,489,000. Neo Ivy Capital Management bought a new stake in shares of Sotera Health in the 3rd quarter worth $720,000. Finally, Barclays PLC raised its position in Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after buying an additional 298,085 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $12.21 on Tuesday. Sotera Health has a one year low of $10.71 and a one year high of $17.08. The company has a 50-day simple moving average of $12.92 and a two-hundred day simple moving average of $14.11. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The company has a market capitalization of $3.46 billion, a PE ratio of 48.84 and a beta of 1.92.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on SHC shares. Barclays dropped their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a research note on Friday, February 28th. The Goldman Sachs Group started coverage on Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.92.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.